Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients—the COFRASA study
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
AIMS: There is currently no medical therapy that can prevent the progression of aortic valve stenosis (AS). Recent data highlight a possible relationship between bone metabolism and AS progression but prospective data are lacking. METHODS AND RESULTS: Serum levels of calcium, phosphorus, creatinine, 25-OH vitamin D, intact parathyroid hormon (iPTH), C-terminal-telopeptide of type-1-collagen (CTX) and osteocalcin were assessed at baseline in 110 elderly patients (age ≥70 years) with at least mild AS. CTX/osteocalcin ratio was calculated as a marker of bone remodelling balance. AS severity was assessed at baseline and 1-year based on the mean gradient. Two-thirds of patients had low 25-OH vitamin D and 20% had secondary hyperparathyroidism. AS progression was not associated with age, glomerular filtration rate (GFR), calcium and phosphorus levels, calcium-phosphorus product, but significantly with iPTH, CTX/osteocalcin and vitamin D status (all P < 0.01). There was no correlation between iPTH and CTX/osteocalcin (R = 0.04, P = 0.70) and AS progression was associated with CTX/osteocalcin (R = 0.42, P = 0.009), but not with iPTH (R = 0.10, P = 0.55) in patients with normal vitamin D levels, whereas it was associated with iPTH (R = 0.47, P < 0.001) and not with CTX/osteocalcin (R = 0.04, P = 0.73) in those with low vitamin D levels, especially if mild renal insufficiency was present (R = 0.61, P < 0.001). CONCLUSION: In elderly patients with AS, we observed an association between AS progression and vitamin D, iPTH and CTX/osteocalcin ratio and their respective influence varied according to the vitamin D status. In patients with normal vitamin D levels, AS progression was associated with a bone resorptive balance, whereas in patients with low vitamin D levels, AS progression was associated with iPTH and secondary hyperparathyroidism, especially if mild renal insufficiency was present. These findings may have important prognostic and therapeutic implications. Trial registration information: Clinicaltrials.gov identifier number: NCT00338676, funded by AP-HP, the COFRASA study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The clinical factors associated with faster stenosis progression include older age, female sex, severity of the stenosis and degree of aortic valve calcification at diagnosis, smoking, hypertension, obesity, metabolic syndrome, secondary hyperparathyroidism, renal failure elevated circulating levels of Lp(a), and increased activity of Lp-PLA2 (also called lipoprotein–associated phospholipase A2)51”
From Calcific aortic stenosis (2016) · cites this paper as [142]
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Authors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
Self-citationIung, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00201-x · Cited by 3,530
Self-citationEchocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice
Baumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Evangelista, A., Griffin, B. P., Iung, B., Otto, C. M., Pellikka, P. A., & Quiñones, M. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.029 · Cited by 2,126
Self-citationClinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
Levey, A. S., Coresh, J., Greene, T., Marsh, J., Stevens, L. A., Kusek, J. W., Van Lente, F., & for Chronic Kidney Disease Epidemiology Collaboration (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077180 · Cited by 1,855
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Self-citationOxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.020 · Cited by 417
“Additionally, other mechanisms may be involved in the older population, including increased dysregulation in mineral metabolism, post-menopausal deficiency in estrogen, and other aging processes (36,37).”
Danielsen, R., Aspelund, T., Harris, T. B., & Gudnason, V. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.053 · Cited by 168
“Vitamin D status, bone remodeling and secondary hyperparathyroidism has also been implicated in AS progression [30].”
BackgroundMedical Treatment of Aortic Stenosis
Marquis-Gravel, G., Redfors, B., Leon, M. B., & Généreux, P. (2016) · Circulation · doi:10.1161/circulationaha.116.023997 · Cited by 162
Pawade, T. A., Doris, M. K., Bing, R., White, A. C., Forsyth, L., Evans, E., Graham, C., Williams, M. C., van Beek, E. J. R., Fletcher, A., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.053708 · Cited by 151
Marwick, T. H., Amann, K., Bangalore, S., Cavalcante, J. L., Charytan, D. M., Craig, J. C., Gill, J. S., Hlatky, M. A., Jardine, A. G., Landmesser, U., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.06.025 · Cited by 164
“Low vitamin D levels are associated with vascular calcification,(17) and in elderly patients with aortic stenosis, renal insufficiency, and low vitamin D levels, aortic stenosis progression has been associated with secondary hyperparathyroidism.(18) Excessive vitamin D supplementation is also associated with valve cal…”
BackgroundSalaun, E., Mahjoub, H., Girerd, N., Dagenais, F., Voisine, P., Mohammadi, S., Yanagawa, B., Kalavrouziotis, D., Juni, P., Verma, S., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035150 · Cited by 119
Evaluating Medical Therapy for Calcific Aortic Stenosis
Lindman, B. R., Sukul, D., Dweck, M. R., Madhavan, M. V., Arsenault, B. J., Coylewright, M., Merryman, W. D., Newby, D. E., Lewis, J., Harrell, F. E., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.1367 · Cited by 111
Determinants of aortic bioprosthetic valve calcification assessed by multidetector CT
Mahjoub, H., Mathieu, P., Larose, É., Dahou, A., Sénéchal, M., Dumesnil, J., Després, J., & Pîbarot, P. (2015) · Heart · doi:10.1136/heartjnl-2014-306445 · Cited by 90
Haemodynamic and anatomic progression of aortic stenosis
Nguyen, V., Cimadevilla, C., Estellat, C., Codogno, I., Huart, V., Benessiano, J., Duval, X., Pibarot, P., Clavel, M. A., Enriquez-Sarano, M., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-307154 · Cited by 81
Self-citationImpact of Plasma Lp-PLA2 Activity on the Progression of Aortic Stenosis
Capoulade, R., Mahmut, A., Tastet, L., Arsenault, M., Bédard, É., Dumesnil, J. G., Després, J.-P., Larose, É., Arsenault, B. J., Bossé, Y., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.09.016 · Cited by 61
“In more advanced disease stages, further mineralization of the AV may be, in large part, determined by phosphocalcic factors (21,22).”
BackgroundThe Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases—A Review
Keller, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112252 · Cited by 52
“In patients with normal vitamin D levels, progression of the disease is associated with bone resorptive balance, whereas in patients with hypovitaminosis D secondary hyperparathyroidism plays a role [161].”
BackgroundOsteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement
Suárez, P. E. S., Arif, S. G., Ahmad, F., Rastogi, N., Meng, A., Cohen, J. M., Rodighiero, J., Piazza, N., Martucci, G. J., Lauck, S., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.0911 · Cited by 55
Tastet, L., Capoulade, R., Shen, M., Clavel, M., Côté, N., Mathieu, P., Arsenault, M., Bédard, É., Tremblay, A., Samson, M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007980 · Cited by 24
Yang, Z., Ying, C., Zhao, H., Fang, Y., Chen, Y., & Shen, W. (2015) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400292 · Cited by 18
Massera, D., Xu, S., Bartz, T. M., Bortnick, A. E., Ix, J. H., Chonchol, M., Owens, D. S., Barasch, E., Gardin, J. M., Gottdiener, J. S., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0347-y · Cited by 21
“A recent study, however, reported an association of circulating biomarkers of bone turnover with progression of AS severity, specifically in a subset with low 25OH vitamin D levels [43].”
Supplemental calcium and vitamin D and long-term mortality in aortic stenosis
Kassis, N., Hariri, E. H., Karrthik, A., Ahuja, K. R., Layoun, H., Saad, A. M., Gad, M. M., Kaur, M., Bazarbashi, N., Griffin, B. P., et al. (2022) · Heart · doi:10.1136/heartjnl-2021-320215 · Cited by 18
AI-Enhanced Prediction of Aortic Stenosis Progression
Sanabria, M., Tastet, L. L., Pelletier, S., Leclercq, M., Ohl, L., Herrmann, L., Mattei, P., Precioso, F., Côté, N., Pîbarot, P., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101234 · Cited by 19
Biomarkers of aortic bioprosthetic valve structural degeneration
Salaün, E., Côté, N., Clavel, M.-A. A., & Pîbarot, P. (2018) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000590 · Cited by 12
Liu, F., & Cai, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1583267 · Cited by 10
Aceña, Á., Peláez, J. A. F., Lázaro, A. M. P., Parra, E. G., González‐Lorenzo, Ó., Martínez‐Milla, J., Hernández‐González, I., Martín‐Mariscal, M. L., Castillo, M. L., Kallmeyer, A., et al. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10050-3 · Cited by 9
“In the study, the most frequent levels were between 25 and 50 nmol/l among patients who did not progress the aortic stenosis [23].”
BackgroundTowards Personalized Therapy of Aortic Stenosis
Mazur, P. K., Kopytek, M., Ząbczyk, M., Undas, A., & Natorska, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121292 · Cited by 12
“Interestingly, very recently Pawade et al. [112] published results from a double-blind controlled trial—SALTIRE2 (Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis, NCT02132026), in which RANKL inhibitors (denosumab or alendronic acid) were ineffective in…”
BackgroundInfluentialLow vitamin D levels affect left ventricular wall thickness in severe aortic stenosis
Verdoia, M., Solli, M., Ubertini, E., Erbetta, R., Gioscia, R., Afifeh, A. M. S., Viglione, F., Rolla, R., & Luca, G. D. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001084 · Cited by 12
Parathyroid hormone is associated with the LV mass after aortic valve replacement
Laflamme, M.-H., Mahjoub, H., Mahmut, A., Boulanger, M., Larose, É., Pîbarot, P., & Mathieu, P. (2014) · Heart · doi:10.1136/heartjnl-2014-305837 · Cited by 10
Mary, A., Hartemann, A., Brazier, M., Aubert, C. E., Kemel, S., Salem, J., Cluzel, P., Liabeuf, S., Massy, Z. A., Mentaverri, R., et al. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.04.008 · Cited by 8
“1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 hyperparathyroidism due to CKD [11], in elderly patients without severe CKD [12] and in 133”
Current Management and Therapy of Severe Aortic Stenosis and Future Perspective
Takeji, Y., Tada, H., Taniguchi, T., Sakata, K., Kitai, T., Shirai, S., & Takamura, M. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22023 · Cited by 7
“The COFRASA study found that CAS progression in elderly CKD patients is related to secondary hyperparathyroidism and low vitamin D levels 97) .”
BackgroundDeterminants of Aortic Stenosis Progression in Bicuspid and Tricuspid Aortic Valves
Shen, M., Tastet, L. L., Capoulade, R., Bédard, É., Arsenault, M., Clavel, M.-A. A., & Pîbarot, P. (2022) · CJC Pediatric and Congenital Heart Disease · doi:10.1016/j.cjcpc.2022.06.004 · Cited by 5
Insights into preclinical models of calcific aortic valve disease and their translational potential
Lafosse, I., Mentaverri, R., Avondo, C., Bennis, Y., Tribouilloy, C. M., & Hénaut, L. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1621990 · Cited by 8
Acceleration of Preexisting Aortic Stenosis After Teriparatide Initiation
Ambalavanan, J., Hubbard, C. A., & Khan, L. Z. (2024) · AACE Clinical Case Reports · doi:10.1016/j.aace.2024.04.006 · Cited by 4
“5”
BackgroundRapid progression of aortic stenosis after initiation of teriparatide treatment: a case report
Solomon, A., & Birkenfeld, S. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000220 · Cited by 5
Mikami, T., Uchiyama, H., Maeda, T., Nakashima, S., Satoshi, M., Sakurada, T., & Araki, E. (2022) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.cr.21-00269 · Cited by 4
“11,12) Since calcification also develops in the aortic valve, it has been reported that AS is likely to occur in patients undergoing hemodialysis.”
BackgroundSuárez, P. E. S., Encuentra-Sopena, M., Almendárez, M., Álvarez‐Velasco, R., Martin-Vega, T., y, P. A., Álvarez, E. M. L., Coto‐Montes, A. M., & Gutiérrez‐Rodríguez, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020334 · Cited by 2
“OH vitamin D levels ( 25 nmol/L or 10 ng/mL), but associated secondary hyperparathyroidism was present in only 20% [22].”
Calcific mitral valve disease: The next challenging disease
Messika–Zeitoun, D., Willner, N. A., & Burwash, I. G. (2022) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2022.09.005 · Cited by 2
Self-citationProgression of valve heart disease in a cohort of patients undergoing renal replacement therapy
Tompson, M. E. C., Pimentel, J. A. V. D. O., Silva, M. D. A., Santos-Veloso, M. A. O., Lordsleem, A. B. D. M. D. S., & de Lima, S. G. (2023) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2023-0036en · Cited by 3
“Presence of osteoblast-like cells, hydroxyapatite crystals, and overexpression of specific bone tissue proteins have been described in calcified valves 26 .”
BackgroundImplications of Renal Disease in Patients Undergoing Structural Interventions
Nagaraja, V., & Kapadia, S. R. (2020) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2020.02.010 · Cited by 2
Tsuruda, T., Funamoto, T., Suzuki, C., Yamamura, Y., Nakai, M., Chosa, E., & Kaikita, K. (2023) · Archives of Osteoporosis · doi:10.1007/s11657-023-01339-2 · Cited by 2
“The imbalance between bone resorption and formation has been suggested to play a role in AS progression [8–10].”
BackgroundAortic stenosis: A complex, atherosclerosis-like, multifactorial disease
Martín, M., Muñoz, J. P. F., Pichel, I. A., Poultel, D. T.-L., Cannata-Andía, J. B., & Rodríguez, I. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.109 · Cited by 1
Valvular Heart Disease: Introduction, Clinical Pathogenesis, and Management
Kunchakarra, S., Puthumana, J. J., & Maganti, K. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_54 · Cited by 1
Place des marqueurs biologiques dans l’exploration du rétrécissement aortique calcifié
Varennes, O., Six, I., Mentaverri, R., & Kamel, S. (2017) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(17)30238-1 · Cited by 1
Olasińska‐Wiśniewska, A., Urbanowicz, T. K., Grodecki, K., Kübler, P., Perek, B., Grygier, M., Misterski, M., Walczak, M., Szot, M., & Jemielity, M. (2023) · Advances in Medical Sciences · doi:10.1016/j.advms.2023.09.011 · Cited by 3
Valve weight in aortic stenosis: back to the basics: Table 1
Iung, B., & Vahanian, A. S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv577 · Cited by 1
“There is now growing interest in the mechanisms involved in the valve calcification process, searching for new metabolic targets in order to slow AS progression.(4)”
BackgroundSelf-citationPhysiopathologie de la sténose aortique : les enseignements de la cohorte COFRASA/GENERAC
Nguyen, V., Arangalage, D., Cimadevilla, C., Codogno, I., & Messika–Zeitoun, D. (2016) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2016.11.005
Self-citationProgression of Aortic Stenosis and Long-term Follow-Up in Women
Amsterdam, E. A. (2021) · Clinical Cardiology and Cardiovascular Interventions · doi:10.31579/2641-0419/147
Kovanen, P. T., & Bäck, M. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755777.003.0015
Progressão da doença cardíaca valvar em coorte de doentes em terapia renal substitutiva
Tompson, M. E. C., Pimentel, J. A. V. D. O., Silva, M. D. A., Santos-Veloso, M. A. O., Lordsleem, A. B. D. M. D. S., & de Lima, S. G. (2023) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2023-0036pt
Rahmani, P., Kavoosi, H., Sadeghi, S., Gharehdaghi, Z., Mashatan, N., Kermanshahi, N., Hatami, A., Keivani, M. M., & Pakmehr, S. (2024) · Cognizance Journal of Multidisciplinary Studies · doi:10.47760/cognizance.2024.v04i04.022
Abbas, M. T., Farina, J., Awad, K., Badr, A., Mousa, H., Pereyra, M., Scalia, I. G., Ali, N. B., Mahmoud, A., Sheashaa, H., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133067
Oh, H. J., Kim, J. H., Lee, K., Ahn, J. Y., Jeong, S. J., Choi, J. Y., Yeom, J., Han, K., & Ku, N. S. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf430
Zhulina, E. M., Brykun, M. V., Саприна, Т. В., Vorojcova, I. N., Tskhay, V. F., & Борисовна, К. Т. (2025) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2025-3-14-24
Déterminants de la progression et de la réponse myocardique dans le rétrécissement aortique calcifié
Arangalage, D. (2018) · theses.fr (ABES) · doi:10.70675/cc101f7dz401ez4bc1zb308za377e4500f20
Le rôle de l'Epoxyde hydrolase soluble (sEH) dans la physiopathologie des calcifications vasculaires
Varennes, O. (2018) · theses.fr (ABES) · doi:10.70675/d554fcf1z9f51z419bz9693z571dd887124a
Imagerie multimodale en cardiologie : application à la surveillance des bioprothèses aortiques
Salaün, E. (2018) · theses.fr (ABES) · doi:10.70675/aeb2f48azf54ez43acz83afz5afcd94a3854
Metadata
- Authors
- Hekimian, G., Boutten, A., Flamant, M., Duval, X., Dehoux, M., Benessiano, J., Huart, V., Dupré, T., Berjeb, N., Tubach, F., Iung, B., Vahanian, A., & Messika-Zeitoun, D.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-17
- Volume
- 34
- Issue
- 25
- Pages
- 1915-1922
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2044635470
- Cited by
- 53
- References
- 43
- Citations by year
- 2025: 6 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 1
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- aortic stenosis, disease progression, bone remodeling, secondary hyperparathyroidism, parathyroid hormone, vitamin D deficiency, 25-hydroxyvitamin D, C-terminal telopeptide of type I collagen, osteocalcin, renal failure, elderly patients, bone metabolism
- MeSH terms
- Aged, Aortic Valve Stenosis, Calcium, Creatinine, Female, Humans, Hyperparathyroidism, Secondary, Male, Parathyroid Hormone, Peptides, Phosphorus, Prospective Studies, Vitamin D, Biomarkers, Osteocalcin, Bone Remodeling, Collagen Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.